close
This ad will auto close in 10 seconds
New drug may treat blood cancer patients

New drug may treat blood cancer patients

Researchers analysed gene expression data from 269 AML patients and found an association between the activity of a group of HOX genes and the patient survival rate.

New hope for greying hair? Side effects of cancer drug turns grey hair brown!

New hope for greying hair? Side effects of cancer drug turns grey hair brown!

Believed to be an isolated case initially, the tables turned when many more patients who used the drug showed the same result.

Drug that re-programmes cells to fight cancer developed in Australia

Drug that re-programmes cells to fight cancer developed in Australia

The therapy involves removing a patient's own immune cells, genetically engineering them to enhance their ability to destroy tumours, and putting them back in the body to fight cancer.

Personalised cancer drug approved in US

Personalised cancer drug approved in US

Pembrolizumab is indicated for the treatment of adult and paediatric patients with unresectable or metastatic solid tumours that have been identified as having a biomarker referred to as microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR).

High Court seeks reason for rejection of prostrate cancer drug patent

High Court seeks reason for rejection of prostrate cancer drug patent

The Delhi High Court has asked the Centre to explain on what basis the Indian patent office has rejected the application by the Regents of University of California seeking a patent for its prostrate cancer drug.

Venetoclax: Wonder drug that 'melts' away cancer approved for human use in Australia

Venetoclax: Wonder drug that 'melts' away cancer approved for human use in Australia

The drug, which was approved for use in the US in August 2016, works by blocking the action of the BCL-2 protein which enables cancer cells to survive, a solution that researchers worldwide have been studying for more than 30 years.

Cancer drug may help increase the number of new eggs in women: Study

Cancer drug may help increase the number of new eggs in women: Study

 A new study has revealed that a treatment with cancer drug may help increase the number of young eggs in women's ovaries.

Pfizer boosts cancer drug roster with $14 billion Medivation deal

Pfizer boosts cancer drug roster with $14 billion Medivation deal

Pfizer Inc, beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company`s growing oncology roster.

Pfizer approaches Medivation about potential takeover

Pfizer approaches Medivation about potential takeover

Pfizer Inc has approached U.S. cancer drug maker Medivation Inc to express interest in an acquisition, raising the possibility of a bid rivaling a $9.3 billion offer by Sanofi SA, people familiar with the matter said on Tuesday.

How alcohol ups breast cancer risk

 Drinking alcohol can put you at increased risk of breast cancer by enhancing the levels of a cancer-causing gene, new research has found.

New molecule to track cancer drug in the body

Scientists have developed luminescent molecule that can light up the path taken by chemotherapy drugs in real time, which could help understand why cancer patients respond differently to the same treatment.

Fungi may lead to cheaper cancer drug

An anti-cancer substance which is already known to be found in yew trees can also be derived from a kind of microbial "bandage" that protects these trees from disease-causing fungi.

Glenmark faces patent infringement suit for cancer drug in US

Glenmark Pharmaceuticals has been slapped with a patent infringement case by US-based Cephalon Inc over plans to sell generic version of leukaemia treatment drug Treanda in the American market.

Roche not to pursue patent for breast cancer drug in India

Swiss pharma major Roche Holding AG Friday said it won't pursue the secondary patent for its breast cancer drug 'Herceptin' in India.

Govt says Roche didn't follow norms for cancer drug patent

The government today said it had "treated as withdrawn" patent applications by Swiss pharma major Roche Holding for offshoot medicines of its breast cancer drug 'Herceptin' because the company did not comply with local norms.

Novartis recovers early losses; stock ends nearly 2% down

After falling about 7 percent and hitting one-year low of Rs 558.10 during the day, shares of the drug firm finally ended at Rs 587.95, down 1.81 percent on the BSE.

Dr Reddy's Lab launches prostate cancer drug in India

Drug firm Dr Reddy's Laboratories Friday said it has launched a cancer drug 'Pamorelin LA' in the country under an agreement with Switzerland-based Debiopharm Group.

Strides Arcolab gets USFDA approval for generic cancer drug

Strides Arcolab Thursday said its wholly-owned arm Onco Therapies has received approval from US health regulator for its generic version of cancer drug Ifosfamide.

Pfizer to challenge patent revocation of cancer drug Sutent

The Indian Patents Office last month issued an order revoking Pfizer's patent of the drug in the country.

Novartis tells SC it has right to patent its cancer drug

The Supreme Court today asked Swiss pharma giant Novartis AG whether it should not sell its anti-cancer drug for Rs 5 each to benefit common man.